FOI release

CEC 253813 FOI Request regarding Amarox.

This request was refused in full, so we didn't provide the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.

Case reference FOI2026/00493

Received 30 April 2026

Published 3 June 2026

Request

Under the Freedom of Information Act 2000, I request confirmation of the following for Sertraline 100mg film-coated tablets, batch V2500425, marketed by Amarox Limited under recall EL(26)A/22: 1)The country and address of the licensed manufacturing site for this batch. 2)The country and address of the licensed site where secondary packaging was carried out. This is for patient safety purposes following the packaging error reported on 28 April 2026.

Response

See attached

Documents

• FOI2026_00493 (redacted).pdf (822.6 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.